Literature DB >> 12111361

Polyneuropathy in neurofibromatosis 2: clinical findings, molecular genetics and neuropathological alterations in sural nerve biopsy specimens.

Christian Hagel1, Matthias Lindenau, Katrin Lamszus, Lan Kluwe, Dimitrios Stavrou, Victor-Felix Mautner.   

Abstract

Neurofibromatosis 2 (NF2) is an autosomal dominant disease characterised by development of tumours in the central and peripheral nervous system. Some NF2 patients develop acro-distal sensory motor polyneuropathy that can hardly be explained by the tumour burden alone. In the present study eight sural nerve biopsy specimens from seven NF2 patients suffering from polyneuropathy were investigated, data including clinical course of the disease, electrophysiological findings, teased fibre preparations, histopathological, morphometric, immunohistochemical, electron microscopic and molecular genetic findings. All patients suffered from distal symmetric reflex loss, symmetrical stocking-like hypalgesia and hypesthesia and loss of vibration sense later followed by a slowly progressive distal muscle atrophy and paresis. Sural nerve biopsy specimens revealed a pathological reduction of nerve fibre density correlating with age. In addition, diffuse proliferation of Schwann cells was observed in five of eight biopsies, and small endoneurial tumourlets of schwannomas and perineuriomas were found in two of eight and one of eight samples, respectively. Ki-67 labelling revealed a slight endoneurial proliferative activity in three cases. Schwann cell onion bulbs with or without central myelinated axon were seen in two cases. The findings suggest an axonopathy of multifactorial origin resulting not only from gross tumour growth but, in addition, from small endoneurial tumourlets, diffuse proliferation of Schwann cells and proliferation of perineurial cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111361     DOI: 10.1007/s00401-002-0535-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  15 in total

1.  [Bilateral acoustic neurinoma].

Authors:  M-A Weber; C Plathow
Journal:  Radiologe       Date:  2003-12       Impact factor: 0.635

Review 2.  Neurofibromatosis type 2.

Authors:  Ashok R Asthagiri; Dilys M Parry; John A Butman; H Jeffrey Kim; Ekaterini T Tsilou; Zhengping Zhuang; Russell R Lonser
Journal:  Lancet       Date:  2009-05-22       Impact factor: 79.321

3.  Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.

Authors:  Kristy Truong; Iram Ahmad; J Jason Clark; Alison Seline; Tyler Bertroche; Brian Mostaert; Douglas J Van Daele; Marlan R Hansen
Journal:  Neuroscience       Date:  2018-02-03       Impact factor: 3.590

4.  Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors.

Authors:  Michael S Dirks; John A Butman; H Jeffrey Kim; Tianxia Wu; Keaton Morgan; Anne P Tran; Russell R Lonser; Ashok R Asthagiri
Journal:  J Neurosurg       Date:  2012-04-13       Impact factor: 5.115

5.  Accumulation of non-compressive fascicular lesions underlies NF2 polyneuropathy.

Authors:  P Bäumer; V F Mautner; T Bäumer; M U Schuhmann; M Tatagiba; S Heiland; T Kaestel; M Bendszus; M Pham
Journal:  J Neurol       Date:  2012-07-04       Impact factor: 4.849

6.  A Prospective Evaluation of Swallowing and Speech in Patients with Neurofibromatosis Type 2.

Authors:  Sibi Rajendran; Joseph Antonios; Beth Solomon; H Jeffrey Kim; Tianxia Wu; James Smirniotopoulos; Gretchen Scott; Sarah Benzo; Christina Hayes; John D Heiss; Prashant Chittiboina
Journal:  J Neurol Surg B Skull Base       Date:  2019-09-18

7.  Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy.

Authors:  Alexander Schulz; Stephan L Baader; Michiko Niwa-Kawakita; Marie Juliane Jung; Reinhard Bauer; Cynthia Garcia; Ansgar Zoch; Stephan Schacke; Christian Hagel; Victor-Felix Mautner; C Oliver Hanemann; Xin-Peng Dun; David B Parkinson; Joachim Weis; J Michael Schröder; David H Gutmann; Marco Giovannini; Helen Morrison
Journal:  Nat Neurosci       Date:  2013-03-03       Impact factor: 24.884

Review 8.  Optimizing biologically targeted clinical trials for neurofibromatosis.

Authors:  David H Gutmann; Jaishri O Blakeley; Bruce R Korf; Roger J Packer
Journal:  Expert Opin Investig Drugs       Date:  2013-02-21       Impact factor: 6.206

Review 9.  The Neurofibromatoses.

Authors:  Said Farschtschi; Victor-Felix Mautner; Anna Cecilia Lawson McLean; Alexander Schulz; Reinhard E Friedrich; Steffen K Rosahl
Journal:  Dtsch Arztebl Int       Date:  2020-05-15       Impact factor: 5.594

Review 10.  Peripheral Nerve Development and the Pathogenesis of Peripheral Neuropathy: the Sorting Point.

Authors:  Stefano C Previtali
Journal:  Neurotherapeutics       Date:  2021-07-09       Impact factor: 6.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.